Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease

April 29, 2016Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.

Post navigation

← 7-Eleven Issues Allergy Alert on Undeclared Peanut in Fresh Fully Baked Chocolate Chunk, Sugar and Oatmeal Raisin Cookies Federal judge enters order of permanent injunction against Paul W. Franck →
Proudly powered by WordPress